Patent Placement Can Impact Compound Value; Is Pfizer Finding Irish Gold?
Executive Summary
Companies acquiring intellectual property should give keen consideration to where the IP is best housed, Celtic Pharma CEO Stephen Evans-Freke said
You may also be interested in...
U.S. Drug Firms Under IRS Scrutiny For Offshore Income Shifting
U.S.-based drug companies inappropriately reported that foreign profits accounted for 66% of their worldwide profits in 2003-2005, 23% more than the amount calculated by Tax Analysts, according to a publication by the non-profit group
U.S. Drug Firms Under IRS Scrutiny For Offshore Income Shifting
U.S.-based drug companies inappropriately reported that foreign profits accounted for 66% of their worldwide profits in 2003-2005, 23% more than the amount calculated by Tax Analysts, according to a publication by the non-profit group
Merck Sees Chance To “Repatriate” Cash To U.S.; GSK Wants To Ship Out
Merck sees an opportunity to bring back cash to the U.S. should a tax change allowing companies to "repatriate" holdings at foreign subsidiaries be enacted by Congress this year